Skip to main content

Table 1 Description of the extension of the Human Genome Epidemiology Network’s Venice criteria to assess genetic main effect

From: Integrative analyses of genes related to femoral head osteonecrosis: an umbrella review of systematic reviews and meta-analyses of observational studies

Criteria of consideration

Category

Proposed operationalization

Amount of evidence

A

Sample size over 1000

B

Sample size 100–1000

C

Sample size under 100

Replication

A

I2 < 50%

B

25% < I2 < 50%

C

I2 > 50%

Protection from bias

A

Consideration biases such as bias in genotyping, population stratification, and Selective reporting biases

B

Bias in genotype definition = Not reported what was done/No quality control checks/Appropriate quality control checks

C

Population stratification = Not reported what was done/Nothing done/Same descent group/Adjustment for reported descent/Family-based design/Genomic control, PCA or similar method

Selective reporting biases = Meta-analysis of published data/Retrospective efforts to include unpublished data/Meta-analysis within consortium

  1. Evidence is classified as strong, moderate, and weak. When scored A in every criteria, evidence is categorized as strong. When scored no C in every criteria but no AAA, evidence is categorized as moderate. Weak evidence is recorded with C in one out of three criteria